Iptacopan Impurtiy 12 - Request Quote
Iptacopan Impurtiy 12
| SZ CAT No: | SZ-I080024 |
| CAS No | NA |
| Mol.F. | C51H62N4O8 |
| Mol.Wt. | 859.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Iptacopan Impurtiy 12 is chemically 4-((2R,4R)-1-((3-((4-(((2R,4R)-2-(4-carboxyphenyl)-4-ethoxypiperidin-1-yl)methyl)-5-methoxy-7-methyl-1H-indol-3-yl)methyl)-5-methoxy-7-methyl-3a,7a-dihydro-1H-indol-4-yl)methyl)-4-ethoxypiperidin-2-yl)benzoic acid. Iptacopan Impurtiy 12 is supplied with detailed characterization data compliant with regulatory guideline. Iptacopan Impurtiy 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Iptacopan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Iptacopan Impurtiy 12
Purchase Iptacopan Impurtiy 12
Iptacopan Impurtiy 12 suppliers
Iptacopan Impurtiy 12 manufacturers
Iptacopan Impurtiy 12 price
Order Iptacopan Impurtiy 12
Enquire Iptacopan Impurtiy 12
Iptacopan Impurtiy 12 cost
Iptacopan Impurtiy 12 Supplier
Iptacopan Impurtiy 12 Distributor
Iptacopan Impurtiy 12 for Method Validation
Iptacopan Reference Standard
Iptacopan Impurtiy 12 for ANDA Filing
Iptacopan Impurtiy 12 for Forced Degradation Studies
Iptacopan Impurtiy 12 Identification Standards
Iptacopan Impurtiy 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.